Assessing the Effect of Cardiac Gene Therapy Using Catheter-Based Pressure–Volume Measurement in Large Animals
Author:
Sakata Tomoki,
Mazurek Renata,
Mavropoulos Spyros A.,
Romeo Francisco J.,
Ravichandran Anjali J.,
Ishikawa KiyotakeORCID
Reference6 articles.
1. Raake PWJ, Tscheschner H, Reinkober J, Ritterhoff J, Katus HA, Koch WJ, Most P (2011) Gene therapy targets in heart failure: the path to translation. Clin Pharmacol Ther 90(4):542–553. https://doi.org/10.1038/clpt.2011.148
2. Pleger ST, Brinks H, Ritterhoff J, Raake P, Koch WJ, Katus HA, Most P (2013) Heart failure gene therapy. Circ Res 113(6):792–809. https://doi.org/10.1161/circresaha.113.300269
3. Greenberg B (2017) Gene therapy for heart failure. Trends Cardiovasc Med 27(3):216–222. https://doi.org/10.1016/j.tcm.2016.11.001
4. Shah AM, Mann DL (2011) In search of new therapeutic targets and strategies for heart failure: recent advances in basic science. Lancet 378(9792):704–712. https://doi.org/10.1016/s0140-6736(11)60894-5
5. Suga H (1979) Total mechanical energy of a ventricle model and cardiac oxygen consumption. Am J Phys 236(3):H498–H505. https://doi.org/10.1152/ajpheart.1979.236.3.H498